Back to search
FDAFDA · Food and drugs·Recall number D-1240-2015

0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68

Published July 22, 2015 · Recall initiated: July 2, 2015

Summary

FDA records drug Class II recall D-1240-2015, published July 22, 2015 and initiated July 2, 2015. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 314600 bags; Lot: Lot #: 49-084-JT; 49-119-JT. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Potential channel leaks near the threaded vial port.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
United States
Lot
Lot #: 49-084-JT; 49-119-JT
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68 recalled?

Yes. FDA published recall D-1240-2015 on July 22, 2015. Reported hazard: Lack of assurance of sterility: Potential channel leaks near the threaded vial port.

What should I do if I have this product?

Voluntary: Firm initiated · Letter